Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 6.00M | $6.0M | 6.31% | -- | 2026-06-30 |
| DAVENPORT & Co LLC | 4.26M | $4.0M | 4.48% | +1.37M | 2026-06-30 |
| Vanguard Capital Management LLC | 3.44M | $3.0M | 3.62% | +437.0K | 2026-06-30 |
| BlackRock, Inc. | 1.26M | $1.0M | 1.33% | +293.6K | 2026-06-30 |
| Geode Capital Management, LLC | 910.0K | $1.0M | 0.96% | -10.2K | 2026-06-30 |
| Renaissance Technologies LLC | 693.3K | -- | 0.73% | -423.8K | 2026-06-30 |
| Hilton Capital Management, LLC | 549.0K | -- | 0.58% | -- | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 508.2K | -- | 0.53% | +44.5K | 2026-06-30 |
| CM Management, LLC | 450.0K | -- | 0.47% | +50.0K | 2026-06-30 |
| Dauntless Investment Group, LLC | 371.7K | -- | 0.39% | -59.3K | 2026-06-30 |
